Table 2.
Aetiology for SARS-CoV-2 molecular testing in tertiary care paediatric departments in Athens (n = 3) and Thessaloniki (n = 1), 1st March—31st May 2020 (n = 1598)
| Month, n (%) | Fever, n (%) | Respiratory symptoms, n (%) | Gastrointestinal symptoms, n (%) | High risk population, n (%) | Testing before surgery, n (%) | Contact with SARS-CoV-2 positive, n (%) |
|---|---|---|---|---|---|---|
| March 264 (16.5) | 199 (75) | 180 (68.1) | 43 (16.2) | 9 (3.4) | 6 (2.2) | 7 (2.6) |
| April 463 (28.9) | 320 (69) | 261 (56.3) | 158 (34.1) | 14 (3) | 34 (7.3) | 26 (5.6) |
| May 871 (54.5) | 614 (70.5) | 360 (41.3) | 248 (28.4) | 21 (2.4) | 129 (14.8) | 34 (3.9) |
| Total (n = 1598) | 1133 (70.9) | 801 (50.1) | 449 (28.1) | 44 (2.8) | 169 (10.6) | 67 (4.2) |
Several children had more than one reasons for testing.